ADPT- Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $53.44M | - | |
| Other | 401.3K | $9.84M | -5,000 | |
| CFO | 256.7K | $6.29M | - | |
| Other | 230.7K | $5.65M | -105,762 | |
| Other | 113.5K | $2.78M | - |
Activity
Buys and sells only
Transactions
10 filings · page 9
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Griffin Michelle Renee80 | Director | Sell | 2,341 | $8.49 | $19,878.13 | -10.2% | -22.8% | -67.0% | |
| Mar 7, 2023 | Taylor Stacy L | SVP And General Counsel | Sell | 18,878 | $8.59 | $162,186.07 | -6.1% | -12.8% | -58.0% | |
| Mar 7, 2023 | Adams R Mark | Chief Operating Officer | Sell | 23,684 | $8.59 | $203,486.53 | -6.0% | -12.8% | -58.0% | |
| Mar 7, 2023 | Sood Nitin | Chief Commercial Officer, Mrd | Sell | 16,474 | $8.59 | $141,476.57 | -3.4% | -12.8% | -58.0% | |
| Mar 6, 2023 | Piskel Kyle | Principal Accounting Officer | Sell | 3,529 | $8.57 | $30,245.82 | -2.0% | -11.3% | -55.3% | |
| Mar 6, 2023 | Lo Francis | Chief People Officer | Sell | 6,816 | $8.57 | $58,413.12 | -3.9% | -11.3% | -55.3% | |
| Mar 6, 2023 | Benzeno Sharon | Chief Commercial Ofc Imm Med | Sell | 11,749 | $8.57 | $100,688.93 | -5.0% | -11.3% | -55.3% | |
| Mar 6, 2023 | Rubinstein Julie | President | Sell | 22,668 | $8.57 | $194,264.76 | -6.3% | -11.3% | -55.3% | |
| Jan 10, 2023 | Adams R Mark | Chief Operating Officer | Sell | 3,125 | $8.55 | $26,732.90 | -1.3% | -3.8% | -46.2% | |
| Nov 16, 2022 | Piskel Kyle | Principal Accounting Officer | Sell | 959 | $8.87 | $8,506.33 | -2.0% | -3.1% | -55.0% |